Clinical Trials Ongoing
Sapience is committed to discovering and developing innovative therapies that address a broad range of cancers. Two of our molecules are currently enrolling patients in the clinical trials below.
A Phase 1-2 Study of Lucicebtide (ST101) in Patients With Advanced Solid Tumors
Phase 2 Enrollment Complete
A Phase 1-2 Study of ST316 in Patients With Advanced Solid Tumors
Enrolling in the United States